340 related articles for article (PubMed ID: 27094195)
21. Outcomes of anti-Müllerian hormone-tailored ovarian stimulation protocols in in vitro fertilization/intracytoplasmic sperm injection cycles in women of advanced age.
Liao CC; Lee RK; Lin SY; Lin MH; Hwu YM
Taiwan J Obstet Gynecol; 2016 Apr; 55(2):239-43. PubMed ID: 27125408
[TBL] [Abstract][Full Text] [Related]
22. Effects of dehydroepiandrosterone supplementation on women with poor ovarian response: A preliminary report and review.
Tsui KH; Lin LT; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):131-6. PubMed ID: 25951716
[TBL] [Abstract][Full Text] [Related]
23. Effect of preconceptional DHEA treatment on in vitro fertilization outcome in poor ovarian respond women: study protocol for a randomized controlled trial.
Wang W; Liu H; Li J; Wei D; Zhang J; Wang J; Ma J; Shi Y; Chen ZJ
Trials; 2019 Jan; 20(1):50. PubMed ID: 30646929
[TBL] [Abstract][Full Text] [Related]
24. Effect of dehydroepiandrosterone administration in Chinese women over 37 years undergoing assisted reproductive techniques.
Liu X; Wang W; Wang X; Qu Q; Hao C
Eur J Obstet Gynecol Reprod Biol; 2016 Jul; 202():9-13. PubMed ID: 27156150
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis.
Narkwichean A; Maalouf W; Campbell BK; Jayaprakasan K
Reprod Biol Endocrinol; 2013 May; 11():44. PubMed ID: 23680224
[TBL] [Abstract][Full Text] [Related]
26. Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF.
Pu D; Wu J; Liu J
Hum Reprod; 2011 Oct; 26(10):2742-9. PubMed ID: 21778283
[TBL] [Abstract][Full Text] [Related]
27. A randomized, controlled, pilot trial on the effect of dehydroepiandrosterone on ovarian response markers, ovarian response, and in vitro fertilization outcomes in poor responders.
Yeung TW; Chai J; Li RH; Lee VC; Ho PC; Ng EH
Fertil Steril; 2014 Jul; 102(1):108-115.e1. PubMed ID: 24796766
[TBL] [Abstract][Full Text] [Related]
28. Dehydroepiandrosterone supplementation improves ovarian response and cycle outcome in poor responders.
Sönmezer M; Ozmen B; Cil AP; Ozkavukçu S; Taşçi T; Olmuş H; Atabekoğlu CS
Reprod Biomed Online; 2009 Oct; 19(4):508-13. PubMed ID: 19909591
[TBL] [Abstract][Full Text] [Related]
29. Dehydroepiandrosterone administration before IVF in poor responders: a prospective cohort study.
Vlahos N; Papalouka M; Triantafyllidou O; Vlachos A; Vakas P; Grimbizis G; Creatsas G; Zikopoulos K
Reprod Biomed Online; 2015 Feb; 30(2):191-6. PubMed ID: 25498594
[TBL] [Abstract][Full Text] [Related]
30. [Effects of cystectomy for ovary benign cyst on ovarian reserve and pregnancy outcome of in vitro fertilization-embryo transfer cycle].
Zhang XR; Ding LL; Tang R; Sheng Y; Qin YY; Chen ZJ
Zhonghua Fu Chan Ke Za Zhi; 2016 Mar; 51(3):180-5. PubMed ID: 27030496
[TBL] [Abstract][Full Text] [Related]
31. Gene expression of cumulus cells in women with poor ovarian response after dehydroepiandrosterone supplementation.
Tsui KH; Lin LT; Horng HC; Chang R; Huang BS; Cheng JT; Wang PH
Taiwan J Obstet Gynecol; 2014 Dec; 53(4):559-65. PubMed ID: 25510701
[TBL] [Abstract][Full Text] [Related]
32. [Effect of luteal-phase gonadotropin-releasing hormone agonist administration on pregnancy outcome in IVF/ICSI cycles: a systematic review and Meta-analysis].
Yu LP; Liu N; Liu Y
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):850-858. PubMed ID: 27916070
[No Abstract] [Full Text] [Related]
33. The Effect of Endometrial Thickness on Pregnancy, Maternal, and Perinatal Outcomes of Women in Fresh Cycles After IVF/ICSI: A Systematic Review and Meta-Analysis.
Liao Z; Liu C; Cai L; Shen L; Sui C; Zhang H; Qian K
Front Endocrinol (Lausanne); 2021; 12():814648. PubMed ID: 35222264
[TBL] [Abstract][Full Text] [Related]
34. Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.
Chern CU; Tsui KH; Vitale SG; Chen SN; Wang PH; Cianci A; Tsai HW; Wen ZH; Lin LT
Reprod Biol Endocrinol; 2018 Sep; 16(1):90. PubMed ID: 30223902
[TBL] [Abstract][Full Text] [Related]
35. Aspirin in women undergoing in vitro fertilization treatment: a systematic review and meta-analysis.
Khairy M; Banerjee K; El-Toukhy T; Coomarasamy A; Khalaf Y
Fertil Steril; 2007 Oct; 88(4):822-31. PubMed ID: 17509593
[TBL] [Abstract][Full Text] [Related]
36. The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve.
Gat I; Blanco Mejia S; Balakier H; Librach CL; Claessens A; Ryan EA
Gynecol Endocrinol; 2016 Jul; 32(7):534-7. PubMed ID: 26829445
[TBL] [Abstract][Full Text] [Related]
37. Effect of levothyroxine supplementation on pregnancy outcomes in women with subclinical hypothyroidism and thyroid autoimmuneity undergoing in vitro fertilization/intracytoplasmic sperm injection: an updated meta-analysis of randomized controlled trials.
Rao M; Zeng Z; Zhao S; Tang L
Reprod Biol Endocrinol; 2018 Sep; 16(1):92. PubMed ID: 30249251
[TBL] [Abstract][Full Text] [Related]
38. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis.
Bosdou JK; Venetis CA; Kolibianakis EM; Toulis KA; Goulis DG; Zepiridis L; Tarlatzis BC
Hum Reprod Update; 2012; 18(2):127-45. PubMed ID: 22307331
[TBL] [Abstract][Full Text] [Related]
39. A prospective study on role of dehydroepiandrosterone (DHEA) on improving the ovarian reserve markers in infertile patients with poor ovarian reserve.
Singh N; Zangmo R; Kumar S; Roy KK; Sharma JB; Malhotra N; Vanamail P
Gynecol Endocrinol; 2013 Nov; 29(11):989-92. PubMed ID: 24004296
[TBL] [Abstract][Full Text] [Related]
40. Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria.
Liu X; Xu J; Bi L; Liu P; Jiao X
Front Endocrinol (Lausanne); 2021; 12():790160. PubMed ID: 34925245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
